1
Luyendijk, Marianne, Blommestein, Hedwig, Uyl-de Groot, Carin, Siesling, Sabine, Jager, Agnes
Veröffentlicht in: Luyendijk , M , Blommestein , H , Uyl-de Groot , C , Siesling , S & Jager , A 2023 , ' Regulatory Approval, Reimbursement, and Clinical Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Metastatic Breast Cancer in the Netherlands ' , JAMA network open , vol. 6 , no. 2 , e2256170 . https://doi.org/10.1001/jamanetworkopen.2022.56170;
2023
Veröffentlicht in: Luyendijk , M , Blommestein , H , Uyl-de Groot , C , Siesling , S & Jager , A 2023 , ' Regulatory Approval, Reimbursement, and Clinical Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Metastatic Breast Cancer in the Netherlands ' , JAMA network open , vol. 6 , no. 2 , e2256170 . https://doi.org/10.1001/jamanetworkopen.2022.56170;
2023
2
de Maar, Josanne S., Luyendijk, Marianne, Suelmann, Britt B.M., van der Kruijssen, Dave E.W., Elias, Sjoerd G., Siesling, Sabine, van der Wall, Elsken
Veröffentlicht in: de Maar , J S , Luyendijk , M , Suelmann , B B M , van der Kruijssen , D E W , Elias , S G , Siesling , S & van der Wall , E 2023 , ' Comparison between de novo and metachronous metastatic breast cancer : the presence of a primary tumour is not the only difference—a Dutch population-based study from 2008 to 2018 ' , Breast Cancer Research and Treatment , vol. 198 , no. 2 , pp. 253-264 . https://doi.org/10.1007/s10549-022-06837-4;
2023
Veröffentlicht in: de Maar , J S , Luyendijk , M , Suelmann , B B M , van der Kruijssen , D E W , Elias , S G , Siesling , S & van der Wall , E 2023 , ' Comparison between de novo and metachronous metastatic breast cancer : the presence of a primary tumour is not the only difference—a Dutch population-based study from 2008 to 2018 ' , Breast Cancer Research and Treatment , vol. 198 , no. 2 , pp. 253-264 . https://doi.org/10.1007/s10549-022-06837-4;
2023